Background
Most studies of small intestinal adaptation have been performed in experimental animals and of these the rat has been the most commonly used species. The experimental data reviewed here are derived from studies in laboratory rats, unless otherwise stated.
During starvation the small intestinal mucosa rapidly atrophies,7-9 with a reduction in cell proliferation being noted within hours of food withdrawal,'0 and this occurs even when the overall nutritional state of the animal is maintained by total parenteral nutrition (TPN).11 12 Conversely, refeeding increases mucosal cell proliferation again, with even an initial rebound effect when cell proliferation increases above pre-starvation values. '3 Studies in the dog as well as the rat have shown that luminal nutrients may stimulate this mucosal proliferation by a local direct action at their site of absorption.'4 15 This direct effect, surprisingly, does not result from the use of the nutrients as sources of energy by mucosal cells, as, in rats, non-metabolisable absorbed substrates, such as galactose and 3-0-methyl-D-glucose, can also promote mucosal cell proliferation.'6 17 This has led to the interesting concept that the 'workload' of absorption determines the proliferative response.'6 17 Luminal nutrients may also stimulate mucosal cell proliferation indirectly by releasing an enterotrophic hormone from the distal small intestine and colon.'8-21
The identity of such a hormone(s) remains uncertain, and although there is circumstantial evidence from studies in humans as well as animals in favour of enteroglucagon,22-24 some recent in vivo and in vitro data have questioned this hypothesis.25-28 A third mechanism by which luminal nutrients may increase mucosal cell proliferation is by stimulating release of pancreaticobiliary secretions, which are themselves trophic to the small intestinal mucosa. [29] [30] [31] At the cellular level both direct and indirect enterotrophic effects of luminal nutrients seem to be mediated by induction of omithine decarboxylase (ODC) and subsequent increases in cellular levels of polyamines. [32] [33] [34] [35] In vitro and in vivo studies suggest that induction of ODC occurs largely at the post-transcriptional level,36 37 in contrast with enteroglucagon synthesis, which results mainly from increased DNA transcription. 38 Adaptive changes in small intestinal mucosal mass are generally accompanied by parallel changes in segmental absorptive function,39A3 but the magnitude of induction of individual transport processes can be selectively influenced by the specific nature of the nutrients within the lumen. Thus in rats receiving TPN, infusion of D-glucose, but not the unmetabolised 3-0-methyl-D-glucose, into the small intestine increases specific transport capacity for glucose,'7 while substituting protein isocalorically for carbohydrate in the diet increases amino acid transport capacity and reduces the transport capacity for galactose.44 INTESTINAL 72 Recent findings suggest, however, that the method by which long chain triglycerides are given itself profoundly influences the proliferative response of the small intestinal mucosa, as boluses increase small intestinal mucosal mass and cell proliferation compared with the same daily dose of fat consumed more gradually as part of a mixed diet.73 This may be because bolus doses of fat enhance release of enteroglucagon from the distal small intestine and colon.73 In a mixed diet substituting long chain triglycerides for glucose does not affect the overall mucosal mass of the small intestine, but does change the distribution of mucosal mass along the small intestine.74
With increasing proportions of long chain triglycerides (and decreasing amounts of glucose) mucosal mass falls in the proximal small intestine and correspondingly rises in the mid small intestine.74 These changes may reflect differences in the sites of absorption of glucose and lipid, with mucosal cells proliferating locally in response to the 'workload' of absorption.'5-17 This finding now also explains why some earlier studies have suggested that dietary fat causes mucosal atrophy in comparison with carbohydrate,7' 72 for in those studies mixed diets were used and measurements were confined to the jejunum and did not include the mid small intestine. By contrast with long chain triglycerides, medium chain triglycerides, which are more rapidly hydrolysed and absorbed,75 maximally stimulate mucosal proliferation in the proximal small intestine when given in mixed diets. 76 77 Essential fatty acids may have an important role in mucosal proliferative responses, as deficiency of this dietary component attenuates the adaptive response of the small intestinal mucosa to partial small intestinal resection78 and also reduces the regenerative response of the mucosa to methotrexate induced injury. 79 Such effects might result from decreases in mucosal concentrations of prostaglandins, which are products of essential fatty acid metabolism and are themselves trophic to the small intestinal mucosa.80 There is little evidence, however, that supplementing the omega 6 fatty acid, linoleic acid above minimum requirements is trophic to the small intestinal mucosa67 and a diet containing 10% by weight of safflower oil (rich in linoleic acid) does not enhance any parameters of mucosal mass during recovery from methotrexate induced mucosal injury over a diet containing 1% by weight safflower oil. 79 The essential fatty acids, however, in fish oil (the omega 3 family) may have special properties. Thus, an oil rich in eicosapentaenoic acid improved mucosal recovery after methotrexate induced injury81 and also stimulated mucosal growth after partial small intestinal resection when compared with other long chain fatty acids. 82 In the diseased or resected small bowel addition of long chain triglycerides to the diet might cause steatorrhoea. The more rapidly hydrolysed and absorbed medium and short chain triglycerides may be better tolerated when small intestinal absorptive capacity is reduced. It is thus of considerable interest that Kripke et a183 found that substituting short chain triglycerides for carbohydrate in a diet enhances the small intestinal adaptive response to distal small bowel resection. Direct infusion of short chain fatty acids into the ileum also stimulates mucosal cell proliferation both in the caecum and in the more proximal jejunum, perhaps by release of a trophic gut peptide.84 Interestingly, intravenously administered short chain fatty acids may stimulate small intestinal mucosal proliferation both in intact animals85 and after partial small intestinal resection.86
The nature of ingested fat may also influence the absorptive function of the small intestine, perhaps as a result of changes in the nature of lipid incorporated into the cell membrane of the enterocyte. Thus Thomson et al have found that a number of specific intestinal transport properties can be varied according to the nature of ingested triglycerides,72 87 101 In addition, as already described, infusion of short chain fatty acids into the ileum can stimulate cell proliferation more proximally,84 perhaps by releasing a trophic gut peptide; in the study of Goodlad et al99 enteroglucagon release was stimulated by the most fermentable fibre. The role of enteroglucagon was questioned, however, by the finding that concentrations of this hormone were high in fibre fed germ free animals,28 even though mucosal proliferation was not increased. 98 The role of bacterial fermentation in mediating the enterotrophic effect of dietary fibre has itself also been disputed. In two studies, the trophic effects of a number of different non-digestible polysaccharides showed little correlation with their fermentability by gut bacteria,27 102 and in rats fed increasing amounts of haricot beans there was no increase in duodenal or caecal cell proliferation, despite increases in short chain fatty acid production in the caecum. 103 Johnson et al27 104 have suggested that the viscosity of the diet may be important as, in their studies, only the most viscous diets increased cell proliferation in the terminal ileum perhaps because these viscous polysaccharides delayed absorption of nutrients and increased their delivery to the terminal ileum. In keeping with this hypothesis, this group has subsequently produced evidence for synergism between the enterotrophic effect of corn oil and a viscous non-starch polysaccharide, guar gum. 105 While the stimulatory effects of dietary fibre on small intestinal mucosal proliferation may prove to be beneficial, it is interesting to speculate that, conversely, the therapeutic efficacy of elemental and polymeric diets in Crohn's disease'06'08 may result from the lack of fibre in these diets. In experimental animals such diets cause mucosal atrophy, especially in the ileum and colon, in relation to standard laboratory diets109 110; this effect could result from the absence of a trophic stimulus to the distal gut that is normally provided by dietary Jenkins, Thompson fibre. It is therefore conceivable that the therapeutic efficacy of these enteral feeds in Crohn's disease is related to such local 'bowel rest' in the distal gut.
Discussion By stimulating mucosal cell proliferation, enteral nutrition may provide clinical advantages to patients after gastrointestinal surgery, especially small bowel resection. In the rat and dog it has been shown that enteral nutrition is essential for stimulating adaptive hyperplasia in the remnant111 112 after partial small intestinal resection, and so a diet that has a potent enterotrophic action might provide great benefit in the short bowel syndrome. In our view, the data suggesting that short chain triglycerides and fatty acids are potent stimulants of mucosal growth hold great promise. The observed enterotrophic effects of intravenously given short chain fatty acids and glutamine also suggest that supplementing parenteral fluid regimens with these nutrients may preserve small intestinal mucosal integrity and function in patients who cannot receive enteral nutrition.
It has also been proposed that maintenance of mucosal integrity may reduce bacterial translocation from the gut and so reduce the incidence of sepsis in critically ill and postoperative patients.2 3 A recent study in patients undergoing elective surgery has challenged this assertion by showing no increase in the incidence of bacterial translocation at the time of laparotomy in patients fed preoperatively by TPN compared with patients who were enterally fed.5' Comparatively fit patients undergoing elective surgery, however, may not be the most relevant group to study, as it is possible that the risk of bacterial translocation is in any case low in such patients. Any beneficial effect of enteral feeding might be more apparent in critically ill patients in whom the risk of bacterial translocation may be increased,2 perhaps as a consequence of mucosal damage resulting from impaired mucosal blood flow.2 113 Indeed, another recent study in patients who had suffered multi-system trauma showed that, compared with TPN, enteral feeding reduced the incidence of sepsis only in severely injured patients."14 Nevertheless, it is debatable whether the protective effects of enteral feeding in such patients are caused by maintenance of mucosal integrity in itself, or whether another mechanism, such as stimulation of local immune function,"15 could be more important. Deitch has shown that there is a poor correlation between the incidence of translocation and parameters of mucosal mass in rats and mice receiving various enteral and parenteral feeds. 1 16 Further research might be directed at assessing further the benefits of enterotrophic dietary regimens in a clinical setting, with particular attention to the incidence of gut derived sepsis in the critically ill patient, to the efficacy of small intestinal adaptation after gastrointestinal surgery, and to amelioration of cytotoxic or radiation induced intestinal injury. Little is known about the molecular mechanisms that mediate the direct enterotrophic actions of absorbed nutrients, and so research in this field may provide a method of further enhancing mucosal proliferative responses to enteral feeding and of adding to our knowledge of the factors that control epithelial cell growth. 
